References
- American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care 2014;37(Suppl 1):S14-S80
- Danish Diabetes Association. Diabetes in Denmark. http://www.diabetes.dk/presse/diabetes-i-tal/diabetes-i-danmark.aspx. Accessed February 2016
- Statistics Denmark. StatBank Denmark. Population of all Denmark, quarter 4 2012. http://www.statbank.dk. Accessed June 2016
- Statens Serum Institute. Dataleverancer og Lægemiddelstatistik [Data Supplies and Medicines Statistics]. Copenhagen, Denmark; 2013. http://medstat.dk. Accessed June 2016
- Dansk Endokrinologisk Selskab. Kliniske retningslinier for behandling af voksne med Type 1 diabetes. http://www.endocrinology.dk/Kliniske%20retningslinier%20-%20DM%20type%201.pdf. Accessed December 2016.
- Dansk Endokrinologisk Selskab. Insulinbehandling af patienter med type 2-diabetes, 2014 revision. http://www.endocrinology.dk/PDF/InsulinbehandlingDM2rev2014.pdf. Accessed December 2016.
- Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-12
- Brod M, Christensen T, Thomsen TL, et al. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health 2011;14:665-71
- Heller SR SR, Frier BM, Herslov ML, et al. Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources. Diabet Med 2016;33:471-7
- Hatting NP, Mikkelsen S. Treatment of hypoglycaemic diabetics in a prehospital setting is safe. Dan Med J 2015;62:A5044
- Jensen MM, Pedersen-Bjergaard U. Self-reported frequency and impact of non-severe hypoglycemic events in insulin-treated diabetic patients in Denmark. Diab Manage 2015;5:67-78
- Domgaard M, Bagger M, Rhee NA, et al. Individual and societal consequences of hypoglycemia: A cross-sectional survey. Postgrad Med 2015;127:438-45
- Horvath K, Jeitler K, Berghold A, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007:CD005613
- Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obesity Metab 2009;11:372-8
- Lane W, Bailey T, Gerety G, et al. SWITCH 1: Reduced hypoglycemia with insulin degludec (IDeg) versus insulin glargine (IGlar), both U100, in patients with T1D at high risk of hypoglycemia: A randomized, double-blind, crossover trial. Poster presented at the American Diabetes Association, 76th Annual Scientific Sessions, June 10–14, 2016, New Orleans, LA
- Wysham C, Bhargava A, Chaykin L, et al. SWITCH 2: Reduced hypoglycemia with insulin degludec (IDeg) versus insulin glargine (IGlar), both U100, in patients with T2D at high risk of hypoglycemia: A randomized, double-blind, crossover trial. Poster presented at the American Diabetes Association, 76th Annual Scientific Sessions, June 10–14, 2016, New Orleans, LA
- Parekh WA, Ashley D, Chubb B, et al. Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool. Diabetic Med J Br Diabetic Assoc 2015;32:1156-66
- Sundhed.dk. Diabetes mellitus in children. https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen/paediatri/tilstande-og-sygdomme/endokrinologi/diabetes-mellitus-hos-boern/. Accessed June 2016
- Ostenson CG, Geelhoed-Duijvestijn P, Lahtela J, et al. Self-reported non-severe hypoglycaemic events in Europe. Diabetic Med J Br Diabetic Assoc 2014;31:92-101
- Pedersen-Bjergaard U, Kristensen PL, Norgaard K, et al. Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia. Curr Med Res Opin 2016;20:1-7
- Kristensen PL, Pedersen-Bjergaard U, Beck-Nielsen H, et al. A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design. BMC Endocr Disord 2012;12:10
- Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, et al. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial. Lancet Diabetes Endocrinol 2014;2:553-61
- Agesen RM, Kristensen PL, Beck-Nielsen H, et al. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial. Diabetes Metab 2016;42:249-55
- Akram K, Pedersen-Bjergaard U, Borch-Johnsen K, et al. Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey. J Diabetes Complic 2006;20:402-8
- Novo Nordisk. Data on file, Available on request.
- International Diabetes Federation (IDF). Diabetes Atlas, Seventh Edition, 2015. http://www.diabetesatlas.org/. Accessed December 2016. Diabetes Atlas, Seventh Edition; 2015
- Geddes J, Schopman JE, Zammitt NN, et al. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabetic Med J Br Diabetic Assoc 2008;25:501-4
- Edridge CL, Dunkley AJ, Bodicoat DH, et al. Prevalence and incidence of hypoglycaemia in 532,542 people with Type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PLoS One 2015;10:e0126427
- Khunti K, Alsifri S, Aronson R, et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obesity Metab 2016;18:907-15
- Brod M, Wolden M, Christensen T, et al. Understanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization. Value Health 2013;16:1140-9
- Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-9
- Brod M, Rana A, Barnett AH. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Curr Med Res Opin 2012;28:1947-58
- Peyrot M, Barnett AH, Meneghini LF, et al. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabetic Med J Br Diabetic Assoc 2012;29:682-9
- Leiter LA, Yale J-F, Chiasson J-L, et al. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypogycemia management. Can J Diabetes 2005;29
- Willis WD, Diago-Cabezudo JI, Madec-Hily A, et al. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res 2013;13:123-30
- Bilde L. International sammenligning af akut ambulancetjeneste. En foranalyse vedrørende finansieringsmæssige og økonomiske aspekter. December 2003. http://www.kora.dk/media/529721/dsi-1422.pdf. Accessed February 2016
- Danmarks Statistik. Forbrugerprisindeks. http://dst.dk/da/Statistik/emner/forbrugerpriser/forbrugerprisindeks. Accessed February 2016
- The Danish Health Data Authority. DRG-takster 2015. http://sundhedsdatastyrelsen.dk/da/afregning-og-finansiering/takster-drg/takster-2015. Accessed February 2016
- Lyngsie PJ, Lopes S, Olsen J. Incidence and cost of hypoglycemic events requiring medical assistance in a hospital setting in Denmark. J Comp Eff Res 2016;5:239-47
- Laegeforeningen. Honorartabel Dagtid 01-04-2016. http://www.laeger.dk/portal/pls/portal/!PORTAL.wwpob_page.show?_docname=11179448.PDF. Accessed April 2016
- Danish Medicines Agency. Prices & Reimbursement. Price of GlucaGen. http://www.medicinpriser.dk/?lng=1. Accessed February 2016
- Danish Medicines Agency. Prices & Reimbursement. Price of glucose-Na-K. http://www.medicinpriser.dk/?lng=1. Accessed February 2016
- Matas. Matas Sports Care Druesukker Pebermynte 100 tabl. https://www.matas.dk/matas-sports-care-druesukker-pebermynte-100-tabl. Accessed February 2016
- Nomeco. MaerkevareSortiment. http://service.nomeco.dk/webdoc/mrkkat.pdf. Accessed February 2016